Wordt geladen...

PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.

INTRODUCTION:Immune checkpoint inhibition has shifted treatment paradigms in non-small cell lung cancer (NSCLC). Conflicting results have been reported regarding the immune infiltrate and programmed death-ligand 1 (PD-L1) as a prognostic marker. We correlated the immune infiltrate and PD-L1 expressi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Malaka Ameratunga, Khashayar Asadi, Xihui Lin, Marzena Walkiewicz, Carmel Murone, Simon Knight, Paul Mitchell, Paul Boutros, Thomas John
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science (PLoS) 2016-01-01
Reeks:PLoS ONE
Online toegang:http://europepmc.org/articles/PMC4841565?pdf=render
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!